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ABSTRACT 
The  main  objective  of  this  study  was  to  focus  on  the  anti-diabetic  activity  of  Cinnamomum  tamala  Linn,  with  special  reference  to  its  curative  and  protective  role  in 
streptozotocin- induced diabetic animal model. Attempts were further made to study the antioxidant properties of Cinnamomum tamala Linn. leaves. The efficacy of 50% ethanolic 
extract of leaves of Cinnamomum tamala showed significant decrease in the blood glucose level and increase in the antioxidant efficacy in streptozotocin induced diabetes. It 
was demonstrated that the oral administration of the 50% ethanolic  extract of leaves of Cinnamomum tamala extract to streptozotocin induced diabetic rats showed significant 
positive changes in the biochemical and physiological parameters related to carbohydrate, protein and lipid metabolism., the strong antihyperglycemic and the anti-oxidant 
effect observed in streptozotocin-induced diabetic rats justified the use of 50% ethanolic  extract of leaves of Cinnamomum tamala  for the treatment of diabetes-related 
complications. 
Keywords: antidiabetic, Cinnamom tamala Linn., anti-oxidant. 
 
INTRODUCTION 
Diabetes  Mellitus  (DM),  is  the  most  common  endocrine  chronic 
disorder  caused  by  inherited  and/or  acquired  deficiency  in 
production of insulin by the pancreas, or by the ineffectiveness of 
the  insulin  produced..  Such  a  deficiency  results  in  increased 
concentrations of glucose in the blood, which in turn damage many 
of the body’s systems, in particular the blood vessels and nerves. 
The  aim  is  to  develop  a  scientifically  validated  and  standardized 
herbal ration which will be useful in the treatment of diabetes. The main 
objective of this study was to focus on the anti-diabetic activity of 
Cinnamom tamala Linn, with special reference to its curative and 
protective  role  in  streptozotocin-  induced  diabetic  animal  model. 
Attempts  were  then  further  made  to  study  antioxidant  properties  of 
Cinnamom tamala Linn. leaves. 
MATERIALS AND METHODS 
Plant material 
The  leaves  of  Cinnamoamum  tamala  (Family  -Liliaceae)  were 
collected  from  Garden  of  National  Botanical  Research  Institute, 
Lucknow,  India  and  was  authenticated  by  Dr.  Sayeeda  Khatoon, 
chemotaxonomist . 
Animals 
Sprague-Dawley rats (150-185g) and Swiss albino mice (20-25 gm) 
of either sex and of approximately the same age were procured from 
the animal house of Central Drug Research Institute, Lucknow. They 
were kept in the departmental animal house at 26 ± 2 °C and relative 
humidity  44  –  56  %  in  polypropylene  cages.  The  animals  were 
exposed to alternate 12 hrs of darkness and light each..Animals were 
provided with standard rodent pellet diet (Dayal, India) and the food 
was  withdrawn  18-24 h  before  the  experiment though  water  was 
allowed ad libitum. All experiments were performed in the morning 
according  to  current  guidelines  for  investigation  of  experimental 
pain in conscious animals. The standard orogastric cannula was used 
for oral drug administration in experimental animals
1. 
Preparation of plant extract 
Method of extraction: Cold percolation process. 
Requirements: Percolater, Shade dried coarse powder of leaves of 
Cinnamoamum tamala . 
Solvents: Petroleum ether and 50% ethanol. 
 
Preliminary Phytochemical Screening 
50% ethanolic extract of Cinnamoamum tamala. was subjected to 
qualitative tests for the identification of various active constituents 
viz. carbohydrate, glycoside, alkaloid, amino acids, flavanoids, fixed 
oil,  tannins,  gum  and  mucilage,  phytosterols  etc.  according  to 
Khandelwal
2. 
Acute toxicity studies (OECD Guideline 423) 
This test involves the administration of a simple bolus dose of test 
substances  to  faster  healthy  young  adult  rodents  by  oral  gavage, 
observation  for  upto  15days  after  dosing  and  recording  of  body 
weight  and  the  necropsy  of  all  the  animals.  In  this  method  pre-
specified fixed doses of the test substances were used ie, 5mg/Kg, 
50mg/Kg,  300mg/Kg,  2000mg/Kg  and  the  mortality  due  to  these 
doses were observed. Generally female animals were used for this 
study and each dose group should consist of 3 animals. 
In Vitro Antidiabetic Activity
3 
α – Amylase  Inhibition  Activity 
Alpha  amylase  enzyme  is  responsible  for  the  metabolism  of 
polysaccharide  such  as  starch  carbohydrate  etc.  the  aim  behind 
present experiment is to study the effect of α-amylase concentration 
on  the  rate  of  reaction  and  inhibition  activity  of  50%  ethanolic 
extract of Cinnamoamum tamala leaves. 
In Vivo Antidiabetic Activity 
Experimental induction of diabetes
4 
All animals were allowed to adapt to metabolic cages for 3 days, 
after  which  they  were  fasted  overnight  and  50  mg/kg  of 
streptozotocine (Sigma, St. Louis, MO, USA) freshly dissolved in 
normal  saline  was  injected  intraperitoneally.  After  treatment,  all 
animals were returned to their cages and given free access to food 
and  water.  Blood  glucose  levels  were  measured  3  days  after 
streptozotocine injection and used as parameter to obtain matching 
pairs of rats with diabetes of similar level of severity. Only rats with 
fasting blood glucose levels greater than 200 mg/dL were considered 
diabetic  and  then  included  in  this  study.  The  mean  blood 
concentration  of  glucose  in  normoglycemic  rats  was  95  mg/dL. 
Diabetic rats were randomly assigned to four different groups (n = 6 
animal/groups). All treatments started 3 days after streptozotocine 
injection. 
Group I  - Control rats received vehicle solution (1% carboxy methyl 
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Group  II  -  Diabetic  control  rats  received  vehicle  solution  (1% 
carboxy methyl cellulose) 
Group III - Diabetic rats treated with extract 200 mg/kg body weight 
in 1% carboxy methyl cellulose 
Group IV - Diabetic rats treated with extract 400 mg/kg body weight 
in 1% carboxy methyl cellulose 
Group V - Diabetic rats treated with Glibenclamide 600 mg/kg body 
weight in aqueous solution 
Glucose estimation 
The collected serum samples of different study group were subjected 
to  the  serum  glucose  level  estimation  by  enzymatic  GOD-POD 
method by using glucose diagnostic kit (Auto-span). 
Total cholesterol estimation 
The serum cholesterol level was estimated by wybenga and pileggi 
method using cholesterol diagnostic reagent kit (span) 
Triglycerides estimation 
The triglycerides level was estimated by Glycerol phosphate oxidase 
(GPO) method. 
Bio-chemical estimation 
Serum  was  analyzed  for  the  following  parameters  aspartate 
aminotransferase/serum  glutamic  oxaloacetic  transaminase 
(ASAT)/(SGOT),  alanine  amino  transferase/serum  glutamate 
pyruvate transaminase (ALAT)/(SGPT), alkaline phosphatase (ALP) 
and cholesterol. 
In Vitro Antioxidant Activity
5 
Free radical scavenging ability (FRSA) by the use of DPPH (1, 1-
diphenyl-2 picrilhydrazyl) 
 
The DPPH radical scavenging activity of PLANT was determined 
by using the method proposed by Yen and Duh (1994). Aliquot of 20 
-  80  µl  (5  mg/  10  ml)  was  added  to  2.9  ml  of  freshly  prepared 
solution  of  DPPH  (6  x  10
-5  M  in  MeOH).  The  Absorbance  was 
recorded at lmax 517 nm after 1 hour of incubation. 
In Vivo Antioxidant Activity 
Assay of lipid peroxidation 
The  concentration  of  thiobarbituric  acid  reactive  substances 
(TBARS)  was  measured  (lipid  peroxidation  product 
maondialdehyde (MDA) was estimated) in liver using the method of 
Okhawa et al
6 
Catalase activity 
CAT activity was determined by monitoring the enzyme-catalyzed 
decomposition  if  hydrogen  peroxide  by  potassium  permanganate 
according to Cohen et al.
 7 
Superoxide dismutase activity
 
SOD was estimated using the standard method of Kakkar et al.
 8.
 
Glutathione peroxidase 
The  incubation  mixture  at  37  °  C  contained  0.08  M  sodium 
phosphate (pH 7.0), 0.08 M EDTA, 1.0 mM sodium azide, 0.4 nM 
GSH and 0.25 mM H2O2. GSH was determined at 3 minute intervals 
using  DTNB.  An  enzyme  unit  represents  a  decrease  in  GSH 
concentration  of  0.001  log  unit  per  minute  after  subtraction  of 
nonenzymic mode. 
. 
Statistical Analysis 
All the values were expressed as mean ± SEM (standard error mean) 
for  six  rats.  Statistical  analysis  was  carried  out  by  using  PRISM 
software package (version 3.0). Statistical significance of differences 
between the control and experimental groups was assessed by One-
way  ANOVA  followed  by  Newman-Keuls  Multiple  Comparision 
Test.  The  value  of  probability  less  than  5%  (P  <  0.05)  was 
considered statically significant. 
Histopathological Studies 
Section of the pancreas and kidney tissues were made, stained with 
Haematoxylin and Eosin reagent and observed under low and high 
power  objective  for  histopathological  changes.  The alteration  and 
changes in the histology of pancreas and kidney were shown in vide 
plate 
RESULTS 
The phytoconstituents were extracted by using different solvent of 
increasing  polarity  like  Petroleum  ether,  Ethanolic(50%).The 
extractive values were presented in table no.1 
Table No 1. Percentage yield of various extracts of leaves of   
Cinnamomum tamala 
Plant used  Part used  Method  Percentage yield 
 
Cinnamomum 
tamala 
 
Leaves 
 
Cold 
percolation 
Petroleum 
ether 
50% 
ethanol 
3.35%w/w  9.75% w/w 
 
Table No. 2. Preliminary phytochemical screening 
S.No  Constituents  Tests  Petroleum ether Extract  50%Ethanolic extract 
1.  Carbohydrate  Molish’s test  +  + 
Fehling’s test  +  + 
2.  Fixed oil & fats  Spot test  +  + 
Saponification test  +  + 
4.  Proteins & amino acids  Million’s test  _  _ 
Ninhydrin test  _  _ 
Biuret test  _  _ 
5.  Saponins  Foam test  _  + 
6.  Phenolic compunds  FeCl3 test  _  + 
Gelatin test  _  + 
Lead acetate test  _  + 
7.  Phytosterol  Salkowiski test  _  - 
Libermann burchard  _  - 
8.  Alkaloids  Dragendroff’s test  _  + 
Mayer’s test  _  + 
Wagner’s test  _  + 
Hager’s test  _  _ 
9.  Gum&mucilage  Swelling test  _  − 
10.  Flavonoids  Aqueous NaOH  _  + 
Con. H2SO4 test  _  + 
Shinoda’s test  _  + Palanisamy P et al. IRJP 2011, 2 (12), 157-162 
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The phytochemical evaluation shows the presence of flavonoid, phenolic compounds, tannins, glycosides, saponins, and carbohydrate in the 
petroleum ether and ethanolic extact. 
Oral Acute Toxicity Studies 
LD50 value of 50 % ethanolic extract of Cinnamomum tamala leaves 
Animals used -  mice 
Weight of animals - 20-25g 
No.of animals per group - 3                          
Route -  oral 
Table no: 3. Oral acute toxicity studies 
SI. No.  No. of animals per Group  Dose  No. of death of  animals 
1  3  5 mg/kg  0 
2  3  50 mg/kg  0 
3  3  300 mg/kg  0 
4  3  2000 mg/kg  1 
 
LD50 value        = 2000 mg/kg 
ED50 value        = 200 mg/kg 
 
In Vitro Antidiabetic Studies 
 
Table No. 4. Observation of 50% ethanolic extract of leaves of Cinnamomum tamala  on a a a a-amylase inhibition activity 
Tube  Amylase  Buffer-ph 6.8  Time until starch disappear (min) 
1  1ml tube1  0.5 ml starch solution 2% Alcoholic extract  20 drops  16 
2  1ml tube2  0.5 ml starch solution 1%  Alcoholic extract  20 drops  14 
3  1ml tube3  0.5 ml starch solution0.5% Alcoholic extract  20 drops  13 
4  1ml tube4  0.5 ml starch solution 0.25% Alcoholic extract  20 drops  11 
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Fig. No. 1. a  Amylase Inhibition Activity of Cinnamomum Tamala 
 
Table No. 5. Anti-diabetic effect (Glucose level) of 50% ethenolic extract of leaves of Cinnamomum tamala (ECT) on streptozotocin induced diabetic rats after 0 and 
21 days 
Groups  Treatment  Dose  0 day (mg/dl)  After 21 days (mg/dl) 
I  Control normal  10 ml/kg  92.33 ± 5.71  92.66 ± 5.88 
II  Diabetic control  55 mg/kg  282.66 ± 26.14
  284.75 ± 25.43
 
III  Streptozotocin+ ECT 200  200 mg/kg  270.16 ± 24.94
a  184.5 ± 16.73
a 
IV 
 
Streptozotocin+ ECT 400  400 mg/kg  272.33 ±23.66
a  159.83 ± 13.22
c 
V 
 
Glibenclamide  600 µg/kg 
 
242.21 ±21.59
a  138.16 ± 11.35
c 
One-way ANOVA 
F 
df 
p 
 
13.36 
4 
<0.001 
 
20.22 
4 
<0.001 
 
Value are expressed as Mean ± SEM of 6 rats in each group and 6 rats in Diabetic control. 
a  =P<.05, b = P < 0.01 ,c = P<.001compared with diabetic control group. 
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Table No. 6. Effect of 50% ethenolic extract of leaves of Cinnamomum tamala (ECT) on the glucose level, cholesterol, and triglyceride in blood serum 
Groups  Treatment  Dose  Glucose level 
(mg/dl) after 21 days 
Cholesterol 
(mg/dl) 
Triglyceride 
(mg/dl) 
I  Control normal  10 ml/kg  92.66 ± 5.88  72.82 ± 6.01  81.25 ± 7.97 
II  Diabetic control  55 mg/kg  284.75± 25.43
  103.61±9.43
  105.79± 9.66
 
III  Streptozotocin+ ECT 200  200 mg/kg  184.5± 16.73
a  82.25± 7.97
a  99.95 ± 8.69
a 
IV 
 
Streptozotocin+ ECT 400  400 mg/kg  159.83± 13.22
c  79.54 ± 8.12
 a  88.99 ± 7.70
a 
V 
 
Glibenclamide  600 µg/kg  138.16 ± 11.35
c  76.71 ±6.76
c  84.01 ± 6.97
c 
One-way ANOVA 
F 
df 
p 
 
20.22 
4 
<0.001 
 
15.76 
4 
<0.001 
 
1.623 
4 
<0.001 
expressed as Mean ± SEM of 6 rats in each group and 6 rats in Diabetic control 
a= P< 0.05, b = P < 0.01 compared with diabetic control group. 
 
Table No. 7 . Effect of 50% ethanolic extract of leaves of Cinnamomum tamala (ECT) on  SGOT, SGPT, and SALP level in blood serum 
Groups  Treatment  Dose  SGOT (U/l)  SGPT (U/l)  SALP (U/l) 
I  Control normal  10 ml/kg  63.59 ± 5.55  21.28 ± 1.89  229.66 ± 21.76 
II  Diabetic control  55 mg/kg  93.73 ± 8.53  49.56± 4.12  296.5 ± 24.04 
III  Streptozotocin+ ECT 200  200 mg/kg  70.91 ± 6.53
 b  37.10 ± 2.47
b  251.16 ± 22.60
 a 
IV 
 
Streptozotocin+ ECT 400  400 mg/kg  67.90 ± 5.85
 a  29.12 ± 2.76
 c  214.66± 21.55
 a 
V 
 
Glibenclamide  600 µg/kg 
 
65.92 ± 5.33
 a  23.16 ± 2.87
 c  202.33 ± 21.71
c 
One-way ANOVA 
F 
df 
p 
 
3.574 
4 
< 0.001 
 
15.76 
4 
< 0.001 
 
2.741 
4 
< 0.001 
expressed as Mean ± SEM of 6 rats in each group and 6 rats in Diabetic control group. 
a= P< 0.05, b = P < 0.01, c = p< .001 compared with diabetic control group. 
 
Table No. 8. Free radical scavenging activity (FRSA) of 50% ethanolic extract of leaves of Cinnamomum tamala (ECT) by the use of DPPH (1, 1-diphenyl-2-
picrilhydrazyl) reduction 
Concentration(µg/ml)  DPPH % inhibition 
200  69.76 ± 2.37 
400  78.39 ± 1.88 
600  84.42 ± 1.79 
800  90.89 ± 2.07 
Values are expressed as Mean ± SEM of triplicate of each sample 
 
Table No. 9 . Effect of 50% ethenolic extract of leaves of Cinnamomum tamala (ECT) on lipid peroxidation, superoxide dismutase, catalase and glutathione peroxidase 
in 21 days 
Groups  Treatment  Dose  LPO 
(n moles/mg of protein) 
SOD 
(units/mg of protein) 
CAT 
(units/mg of protein) 
GPx 
(m moles/gm) 
I  Control normal  10 ml/kg  0.31 ± 0.02  145.70 ± 13.42  44.51 ± 4.21  7.05 ± 0.9 
II  Diabetic control  55 mg/kg  0.86 ± 0.08  108.39 ± 10.65  17.26 ± 1.10  1.95 ± 0.2 
III  Streptozotocin+ ECT 
200 
200 
mg/kg 
0.42 ± 0.04
a  134.18 ± 11.66
a  31.51 ± 2.12
b  3.66 ± 0.4
a 
IV 
 
Streptozotocin+ ECT 
400 
400 
mg/kg 
0.39± 0.03
c  139.85 ± 11.51
a  37.14 ± 3.21
c  4.55 ± 0.8
a 
V 
 
Glibenclamide  600 µg/kg  0.36 ± 0.031
c
  142.40 ± 12.18
 a  39.31 ± 3.94
 c  5.71 ± 0.35
c 
One-way ANOVA 
F 
df 
p 
 
24.20 
4 
< 0.001 
 
1.579 
4 
<0.001 
 
11.04 
4 
< 0.001 
 
10.68 
4 
<0.001 
Expressed as Mean ± SEM of 6 rats in each group and 4 rats in Diabetic control 
a= P< 0.05, b = P < 0.01 c = p<.001 compared with diabetic control group 
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Histopathological studies 
The  normal  architecture  was  restored  to  the  same  as  that  of  the 
standard drug (Glibenclamide) treated kidney (figure no. 3. J). This 
is  evident  that  50%  ethanolic  extract  of  leaves  of  Cinnamomum 
tamala posses good antidiabetic and antioxidant activity. 
I) Pancreas 
 
 
(A)  Normal Control 
 
 
 
(B)  Diabetic Control 
 
 
 
(C)  Diabetic + ETC 200 
 
 
 
(D)  Diabetic + ECT 400 
 
 
 
(E)  Diabetic + Standard 
Fig. No. 2 (A) Normal Control 
(B) Diabetic Control 
(C) Diabetic + ETC 200 
(D) Diabetic + ECT 400 
(E) Diabetic + Standard 
II) Kidneys 
 
 
(F)  Normal Control 
 
 
 
(G)  Diabetic Control 
 
 
 
(H)  Diabetic + ECT 200 
 
 
 
(I) Diabetic + ECT 400 
 
 
 
(J)    Diabetic + Standard 
Figure 3 : (F) Normal Control 
(G) Diabetic Control 
(H) Diabetic + ECT 200 
(I) Diabetic + ECT 400 
(J) Diabetic + Standard 
CONCLUSION 
The present study revealed that the 50% ethanolic extract of leaves 
of Cinnamomum tamala not only possess good antihyperglycemic 
properties  but  also  have  very  good  antioxidant  activity  in 
streptozotocin induced diabetic condition. The 50% ethanolic extract 
of  leaves  of  Cinnamomum  tamala,  which  shows  diabetes  biology 
and pharmacology lead to rapid development in diabetes treatment. Palanisamy P et al. IRJP 2011, 2 (12), 157-162 
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In addition to this, studies on molecular aspect of diabetic therapy 
will  give  mechanistic  information  in  diabetes  therapy  and  also 
critical  balance  should  be  there  between  the  animal  model  and 
clinical  research.  This  holds  great  promise  for  future  research  in 
human beings.  
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